Tumor size decrease was consistent across previously analyzed and unanalyzed samples ( all mutation subgroups ) , with less consistency across ORRs in mutation-negative cytology ( 16 % ) and histology ( 25 % ) subgroups versus the previous analysis ( 1 % ) .